Philips Unit Inks $14.7M FCA Deal For Cardiac Monitoring Bills
Philips-owned BioTelemetry Inc. and its subsidiary will pay over $14.7 million to settle False Claims Act allegations that they inflated federal healthcare reimbursements for six years by inducing providers to bill for...To view the full article, register now.
Already a subscriber? Click here to view full article